How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’
Rather than leave the work of developing relationships in China to individual companies, the firm launched an initiative called RA Capital Swiftbridge in mid-20...
Rather than leave the work of developing relationships in China to individual companies, the firm launched an initiative called RA Capital Swiftbridge in mid-2025.